A next-generation CRO dedicated to empowering pharmaceutical enterprises and research institutions worldwide through integrated, disease biology–driven R&D solutions.
Dedicated to scientific assessment, innovation translation, and life quality improvement.
TriApex
With a strong focus on clinical value, we have developed deep expertise and significant experience in cardiometabolic diseases, CNS diseases, ophthalmology, autoimmune diseases and oncology. We provide a comprehensive suite of nonclinical safety, efficacy and DMPK studies, alongside integrated clinical trial services spanning POC to pivotal trials, supporting our clients throughout the R&D lifecycle.
95000
㎡+
Total area of our major facilities (Nanjing, Shanghai, Kunming, Wenchang and North Wales, Pennsylvania)